InsiderSignal.AI

InsiderSignal.ai

PRCT - Procept Biorobotics Corp

Insider Sale by Nouri Alaleh (EVP, CLO, CORP. SEC.)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Nouri Alaleh, serving as EVP, CLO, CORP. SEC. at Procept Biorobotics Corp (PRCT), sold 5,363 shares at $25.96 per share, for a total transaction value of $139,231.00. Following this transaction, Nouri Alaleh now holds 105,354 shares of PRCT.

This sale represents a 5.00% decrease in Nouri Alaleh's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 19, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 19, 2026, meaning the disclosure happened on the same day as the trade.

Procept Biorobotics Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Nouri Alaleh

EVP, CLO, CORP. SEC.

Alaleh Nouri is the Executive Vice President, Chief Legal Officer, and Corporate Secretary at PROCEPT BioRobotics Corp (PRCT), a medical device company specializing in innovative robotic systems for urology procedures.[[1]](https://fintool.com/app/research/companies/PRCT/people/alaleh-nouri)[[3]](https://www.gurufocus.com/news/8704817/insider-sell-alaleh-nouri-sells-shares-of-procept-biorobotics-corp-prct)[[5]](https://www.marketbeat.com/instant-alerts/procept-biorobotics-nasdaqprct-evp-sells-16334040-in-stock-2026-03-09/) She joined the company in July 2018 as SVP, General Counsel & Corporate Secretary, advanced to her current role in January 2022, and has served as Chief Compliance Officer since September 2018.[[1]](https://fintool.com/app/research/companies/PRCT/people/alaleh-nouri) Nouri, age 46, holds a J.D. from U.C. College of the Law, San Francisco (formerly U.C. Hastings) and a Bachelor of Commerce in International Business with a finance specialization from the University of British Columbia.[[1]](https://fintool.com/app/research/companies/PRCT/people/alaleh-nouri) Recent insider trading includes sales of 6,892 shares on March 6, 2026, for $163,353 under a Rule 10b5-1 plan, and 3,243 shares on March 10, 2026, with total sales of 10,451 shares over the past year; she currently owns 111,021 shares.[[2]](https://www.investing.com/news/insider-trading-news/alaleh-nouri-evp-at-procept-biorobotics-sells-163k-in-shares-93CH-4550786)[[3]](https://www.gurufocus.com/news/8704817/insider-sell-alaleh-nouri-sells-shares-of-procept-biorobotics-corp-prct)[[4]](https://www.stocktitan.net/sec-filings/PRCT/form-4-procept-bio-robotics-corp-insider-trading-activity-44b9463dadb1.html)[[5]](https://www.marketbeat.com/instant-alerts/procept-biorobotics-nasdaqprct-evp-sells-16334040-in-stock-2026-03-09/) During her tenure, PRCT achieved 65% YoY revenue growth to $224.5 million in 2024, alongside key FDA approvals and milestones.[[1]](https://fintool.com/app/research/companies/PRCT/people/alaleh-nouri)

View full insider profile →

Trade Price

$25.96

Quantity

5,363

Total Value

$139,231.00

Shares Owned

105,354

Trade Date

Thursday, March 19, 2026

4 days ago

SEC Filing Date

Thursday, March 19, 2026

HEALTHCAREMEDICAL DEVICES

About Procept Biorobotics Corp

Company Overview

No company information available
View news mentioning PRCT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4921952

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime